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the normal AM volume, and that complete cessation of
clearance occurs when this phagocytized volume reachesIt is more than 25 years ago that the late Paul Morrow
published his paper entitled “Possible mechanisms to ex-
plain dust overloading of the lungs” [1]. The paper had a
major impact on our thinking on the retained dose and
clearance upon inhalation of respirable dust. We have to
realize that in those years’ asbestos, man-made mineral
fibres and coal-mine dust induced pulmonary diseases
dominated the publications. Particle and Fibre Toxicol-
ogy was not yet started, and fundamental discussions on
general particle paradigms were disseminated through* Correspondence: paul.borm@zuyd.nl
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unless otherwise stated.Inhalation Toxicology and general Toxicology journals,
such as the journal chosen by Paul Morrow, Fundamen-
tal and Applied Toxicology. Ambient fine particles and
nanoparticles were not yet explored by particle toxicolo-
gists, [which is hard to imagine] in stark contrast to these
days, where 90% of papers in Particle and Fibre Toxicol-
ogy focus on nanomaterials, and fundamental mecha-
nisms of particle induced cell damage.
Morrow [1] proposed the lung particle overload hy-
pothesis based on a careful analysis of many publications
on effects and disposition of particles delivered to the
lungs of rodents. At the core of the particle overload hy-
pothesis is the question about the relevancy for humans
of both non-neoplastic and neoplastic effects observed
specifically in rats exposed chronically to extremely high
concentrations of poorly soluble particles of low acute
toxicity (PSP). Morrow proposed that a continuously in-
creasing prolongation of particle lung clearance of PSP
occurs when the retained lung burden exceeds a certain
threshold; he identified that this effect on particle clear-
ance is due to an impairment of the alveolar macrophage
(AM) clearance function and concluded from his ana-
lysis of the data that the impaired clearance correlates
with the phagocytized volumetric loading of AM. More
specifically, he suggested that the impairment starts when
the average composite phagocytized volume exceeds 6% of
60% of the normal AM volume. Morrow proposed to test
this hypothesis by administering tracer doses (below over-
load) of radioactively-labelled either 3 μm or 10 μm poly-
styrene spheres to rats, the volume of one 10 μm sphere
(600 μm3) being equivalent to ~60% of a rat’s AM volume.
The clearance of both particle sizes via in vivo counting of
chest radioactivity over 6 months in a collimated detector
system confirmed that the 10 μm particles were not
cleared, whereas the 3 μm particles cleared with a rat spe-
cific normal retention T½ of 80 days [2]. Indeed, examin-
ation of lung lavage samples showed that AM had readily
phagocytized the large spheres so that one sphere com-
pletely filled one AM (Figure 1).his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 SEM picture of Alveolar Macrophages in lung lavage of a
rat 24 hrs after instillation of 10.3 μm polystyrene spheres: AM in
foreground with 1 phagocytized sphere showing no clearance;
normal functional AM with ruffled surface in background [2].
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search into the fate of particles in the lung under normal
and overload conditions; for example, an increasing inter-
stitial access of particles associated with overload [3]; or,
the finding that a decrease in the alveolar inflammatory
response despite increasing doses of ultrafine TiO2 – as
indicated by the number of inflammatory neutrophils in
lung lavage samples – may be explained by a shift of the
inflammation from the alveolar space to the interstitium
when more than 50% of the lung deposited dose has trans-
located to the pulmonary interstitium [4]. Could such
interstitial shift of inflammation explain results in coal
miners where a large portion of very high lung burdens –
consistent with overload – translocated to the interstitium
so that no increase of neutrophils in lung lavage is seen.
And, may this primate-specific interstitial particle seques-
tration compartment [5] explain that coal miners – in
contrast to rats – do not have an increased risk of lung
cancer under lung overload conditions?
Morrow [1] also recognized that other metrics be con-
sidered in the ongoing discussion about the “overload”
phenomenon; in particular he co-authored a paper indi-
cating that severely retarded AM clearance of test parti-
cles following sub-chronic inhalation of ultrafine TiO2 in
rats occurred at AM phagocytized doses far below the
6% AM threshold volume, but that the phagocytized par-
ticle surface area correlated very well with the observed
clearance impairment of both the ultrafine and fine TiO2
[6]. Even taking into account the void spaces between the
agglomerated phagocytized particles in AM did not im-
prove the correlation between retained volumetric lung
burden of TiO2 and impaired particle clearance orpulmonary inflammation, in contrast to the adequate
correlation with retained TiO2 surface area. Since then,
the importance of the particle surface area dosemetric
for particle-induced pulmonary inflammatory effects has
been repeatedly shown by many investigators [7-11].
The fascination with Morrow’s theory on particle over-
load continues, particle overload has been at the centre
of debate for over 25 years, even at times when we were
discussing particles with different sizes, at much lower
concentrations and exposure conditions. The overload
concept has upstaged debates at many public, scientific,
regulatory and personal meetings. In 1998, an inter-
national workshop by ILSI in Washington set the stage for
a larger debate with two main objectives [12]: (1) provide
guidance for risk assessment on the interpretation of neo-
plastic and non-neoplastic responses of the rat lung to
PSPs; and (2) to identify important data gaps in our under-
standing of the lung responses of rats and other species to
PSPs. The consensus of the workshop participants was:
“Because it is still not known with certainty whether
high lung burdens of PSPs can lead to lung cancer in
humans via mechanisms similar to those of the rat,
in the absence of mechanistic data to the contrary it
must be assumed that the rat model can identify
potential carcinogenic hazards to humans. Since the
apparent responsiveness of the rat model at overload is
dependent on coexistent chronic active inflammation
and cell proliferation, at lower lung doses where
chronic active inflammation and cell proliferation are
not present, no lung cancer hazard is anticipated”.
In 2000, a workshop on fibre and particle toxicology
was organized by the German Permanent Senate Com-
mission for the Investigation of Health Hazards of Chem-
ical Compounds in the Work Area (MAK Commission) in
Munich to revisit similar topics with an update on emer-
ging biological mechanisms such as particle induced pul-
monary inflammatory response, anti-oxidant protection
and secondary genotoxicity of particles due to inflamma-
tion under overload conditions.
The workshop participants concluded [13] that “the
lung tumors observed in chronic rat inhalation studies
with high dose PSPs … are due to a secondary genotoxi-
city”, which in rats “operates only at high doses and high
levels of neutrophils” and for “PSP, pathology in rodents
indicates that if there is no inflammation there is no fi-
brosis, and if there is no fibrosis, there is no cancer”. The
participants also noted that surface area of PSPs is an
important dose-metric and recommended that particle
surface area should be measured, along with number,
mass and diameter. Concerning species differences re-
garding DNA repair and other defence mechanisms, the
participants agreed “that at present there is no better
Borm et al. Particle and Fibre Toxicology  (2015) 12:10 Page 3 of 5animal model than the rat for assessing lung cancer risk
for PSP. The rat appears to be the only laboratory ani-
mal species that develops lung tumours in response to
PSP and, therefore, is the most sensitive species for this
endpoint”. Still, the participants recognized that “It is un-
known whether in humans secondary PSP-induced DNA
damage could occur at extremely high retained particle
levels in the lung. However, this appears unlikely, since
even among coal workers who have been chronically ex-
posed to very high dust levels, rates of lung tumors are
not significantly increased”.
In the late nineties, the Medical Institute for Environ-
mental Hygiene (MIU) in Düsseldorf, completed a life-
time animal study with 19 different particles at different
doses started by the late Friedrich Pott and co-workers
[10,14,15]. In this study a series of particles were admin-
istered at high doses to rats by intratracheal instillation,
to apply and prove the Morrow-volumetric overload hy-
pothesis and at the same time determine induction of
lung cancer by these particles. The work has initiated a
lot of discussion and debate with basically two views:
people that supported the “surface” hypothesis, while the
others considered the concept of “volumetric” overload as
the prime mechanism leading to tumours. More import-
ant however, was the split in opinions regarding the rele-
vance of the theory to humans, if so how extrapolation
should occur. Both the ILSI workshop in 1998 [12] and
MAK workshop in 2000 [13] were not conclusive on this
topic, since data to support it were missing.
Today we still see that the above issues are not entirely
solved and that the debate is ongoing. We have invited
two groups, that is Jürgen Pauluhn (formerly Bayer) and a
group of authors led by Peter Morfeld (Evonik, Germany)
to review the literature and to summarize the current
views on particle lung overload and the relevance to pre-
dict the carcinogenic potency of PSPs. Morfeld and col-
leagues [16] argue that the host defence mechanisms and
particle retention metrics in rats are entirely different than
those in humans (or even other rodents). However, this is
what the German MAK committee is adapting and the
result is a rather precautionary exposure limit value [17].
Morfeld et al. contend that the classification depends
highly on debatable assumptions and calculations on lung
particle overload by software which is not freely available
as it is for the Multiple Path Particle Dosimetry model.
They argue that the total surface area of particles retained
in the lung is the more appropriate metric for the inflam-
mation and impaired clearance function. On the other
hand, Pauluhn in his paper [18] argues that the existing
information on mechanistic information, primarily lung
inflammation and particle retention kinetics, is by and
large driven by the volumetric particle dose and the AM
pool, because this determines the percentage of macro-
phage volume that is displaced by particles leading tooverload and associated impaired clearance function.
However, Pauluhn also acknowledges that surface area
and in particular surface chemistry and associated po-
tential for particle dissolution play a role in the develop-
ment of host responses so that volume may not be the
only critical parameter that determines the likelihood of
a carcinogenic potential of PSPs.
Both Pauluhn [18] and Morfeld et al. [16] cite the pa-
pers by Cullen et al. [19] and Tran et al. [7] describing
effects, deposition and retention kinetics and lung lavage
neutrophil data of inhaled BaSO4 and TiO2 particles in
rats, and came to divergent conclusions. Morfeld et al.
[16] concurred with the conclusion of the authors that
particle surface area rather than volume or mass was the
appropriate metric to confirm that both particle types
are PSP particles; whereas Pauluhn [18] pointed to an
enhanced dissolution of BaSO4 when fitting the data of
the accumulation phase. Indeed a recent study [20] in rats
with inhalation and intratracheal instillation of nano-sized
BaSO4 reported that 95% of the retained lung burden of
BaSO4 was cleared within 34 days post-inhalation and that
the retention halftime of instilled BaSO4 was less than
10 days. This is significantly faster than a normal T½ of
60–80 days for both modes of BaSO4 delivery to the lung.
Is this consistent with a PSP (poorly soluble) category for
BaSO4? Whatever the final judgement on the studies by
Cullen et al. [19] and Tran et al. [7] is, these studies provide
an important contribution to the overload discussion in
terms of not only viewing accumulation and retention kin-
etics of the inhaled particles but also determining in vivo
particle dissolution rates. The result of Konduru et al. [20]
reflects either an efficient rapid translocation of the 20 nm
BaSO4 particles, or a high dissolution rate. Clearly, studies
aimed at generating new insights regarding the fate of
phagocytized particles in AM of rodents and primates are
required to advance our thinking about the 25-year old
phenomenon of lung particle overload.
After reading both invited reviews, some conclusions
and questions can be summarized as:
 Before lung particle overload was brought to the
attention of the scientific community by the late
professor Morrow, Davies [21] had concluded from
studying dust accumulation and retention in the
lungs of coal miners that an observed greatly
enhanced rate of accumulation “must be associated
with an increased likelihood of a particle being
retained in the lungs after it has been deposited
upon the surface of an alveolus”.
 Impaired alveolar macrophage clearance function for
particles remains the hallmark of lung particle
overload. The originally proposed mechanism for
such impaired clearance in terms of volumetric
loading of AM still seems to hold for larger
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dose-metric is a valid alternative, especially when
nanoparticles are involved, knowing that surface
properties and chemistry can make a significant
difference in terms of particle-cell interaction which
is not associated with simply the volume of the
particle in question [22-25].
 The dissolution rate of the phagocytized particles
inside a phagolysosome is an important determinant
of the particulate state; regardless as to whether the
volume or surface area is considered as dose-metric.
Also, significant differences between rodents
and primates regarding interstitial particle
sequestration and associated retention kinetics
need to be considered.
 Regarding extrapolation modelling of results from
rat overload studies to human exposure conditions -
some of the open questions to be discussed are:
should the normalization of retained lung burdens
preferably be based on the denominator alveolar
surface area, lung weight, or AM number?
 Which value for alveolar surface area should be
used: Surface area at total lung capacity (TLC), at
functional residual capacity (FRC)? Obviously,
normal breathing occurs at FRC + tidal volume (TV),
so the average surface area for particle deposition to
consider during breathing is FRC +½ TV.
 Is dosimetric extrapolation modelling of results from
long term particle inhalation studies in rats
meaningful? A fundamental question is, which
retention T½ for humans should be used? Options
based on Gregoratto (2010) might be: clearance
from the alveolar space to the mucociliary escalator
(T½ = 400 days, for 60% of alveolar deposit), or
clearance from the alveolar space to the interstitium
(T½ = 700 days, for 40% of alveolar deposits),
or combined clearance from the alveolar space
to the mucociliary escalator and interstitium
(250 days, for 100% of alveolar deposits) as
sequestration compartment
 What is the biologically effective/available surface
area? BET surface area is generally used as a
surrogate based on studies showing good
correlations with responses, however, are there
better alternatives? Might the specific surface
reactivity be a more relevant metric, expressed as
response per unit particle surface area, and useful
for purposes of hazard ranking (Rushton et al. [26]).
 Is there evidence for particle overload associated
impaired clearance in humans? There seems to be
conditional evidence in coal miners as indicated
by Davies [21] and based on calculations by Stöber
et al. [27] using autopsied lung samples from
miners and from actual magneto-pneumographicmeasurements of dust retention in coal miners’
lungs by Freedman and Robinson [28].
In a time when kinetics and overload belong to old
school descriptive toxicology, we felt it is our obligation
to bring the discussion back to the scientific forum and
out of the risk assessment arena. In addition, for our
younger readers who are mainly focused on molecular
mechanistic endpoints within specific area’s such as the
inflammasome, DNA repair or oncogene-regulation, this
may also be a message that findings need to be viewed
and interpreted in a translational context. Driven by the
new events such as SCOEL using the overload approach
using a volumetric approach and defining elimination kin-
etics to half-times exceeding 60-days, and AM pool size as
the key elements] for setting occupational exposure levels
in the EU, the editor of PFT decided to invite key players
in the field to give their opinion on the most important
events of the past 10–15 years, and give their opinion on
dose-metrics and rat-human extrapolation. Both the sub-
mission and reviewing process showed how topical the
overload issue still is, including the impact and debate on
its use for risk assessment. At the same time it is interest-
ing to note that some toxicologists don’t even realize what
the debate is all about. We hope that with this mini-series
of 2 papers [16,18] we have positioned the debate in the
current time frame. We believe this enables the argu-
ments to be separated from the political arena, allowing
a renewed objective debate. This procedure goes back to
the roots and mission of the founding of our open-
access journal, dedicated to general aspects of particle
and fibre toxicology [29].
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